²é¿´: 7827  |  »Ø¸´: 29
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

³ÕÃÎäìÏæ

ľ³æ (ÖøÃûдÊÖ)


[½»Á÷] ÖµµÃ¾«¶ÁµÄһƪ¹úÄÚ·¢±íµÄNature Chemical Biology ÒÑÓÐ27È˲ÎÓë

¹úÄÚ²ÎÓ뵥λ£º¹ú¼ÒÉúÃü¿ÆÑ§Ñо¿Ëù¡¢Ìì½ò´óѧ
ÕâÆªÎÄÕÂÈ·Ö¤ÁËËÀÍöÊÜÌåDR5×÷Ϊ¿¹Ö×Áö°Ð±ê£¬²¢É¸Ñ¡³öµÚÒ»¸öС·Ö×ÓÏȵ¼»¯ºÏÎ¹±Ï×ºÜ´ó£¬Æª·ù½Ï¶Ì£¬¸²¸Çµ±´úÉúÎﻯѧ¸÷ÖÖ¼¼Êõ£¬·Ç³£ÖµµÃ¾«¶Á¡£ÎÄÕÂÄÚÈݼ°±³¾°´óÌåÈçÏ£º
ϸ°ûµòÍö£¨apoptosis£©ÓÐÈýÌõÐźÅͨ·£¬¼´£ºËÀÍöÊÜÌåÐźÅͨ·¡¢ÏßÁ£ÌåÐźÅͨ·¡¢ÄÚÖÊÍøÐźÅͨ·£¬ÆäÖеÚÒ»ÌõΪÍâÔ´ÐÔÐźÅͨ·£¨extrinsic pathway£©£¬ºóÁ½ÌõΪÄÚÔ´ÐÔÐźÅͨ·£¨intrinsic pathway£©¡£
ͼ1. ϸ°ûµòÍöÐźÅͨ·

ͼ2. ËÀÍöÊÜÌåÐźÅͨ·

ËÀÍöÊÜÌ壨death receptors£©ÊÇÒ»ÖÖ¿çĤµ°°×£¬ÓÐTNFÊÜÌå¡¢FasLÊÜÌå¡¢DRÈý´óÀ࣬Æä°ûÍâÇø£¨extracellular domain£©ÓëÏàÓ¦µÄÅäÌå½áºÏºó£¬¾ÛºÏÐγÉͬԴÈý¾ÛÌå¡£Èý¾ÛÌ帴ºÏÎïͨ¹ýÆä°ûÄÚµÄËÀÍö½á¹¹Óò£¨death domain£©£¬ÓëÏνӵ°°×£¨adaptor protein£©FADD½áºÏ¡£FADDÒ»ÖÖÁ¬½Óµ°°×£¬C-¶ËΪËÀÍö½á¹¹Óò£¬N-¶ËΪËÀÍöЧӦ½á¹¹Óò£¨death-effector domain£©£¬Äܹ»ÓëCaspase-8½áºÏ£¬ÐγÉËÀÍöÓÕµ¼ÐźŸ´ºÏÌ壨death-inducing signaling complex£¬DISC£©¡£
TNF£ºtumor necrosis factor£¬Ö×Áö»µËÀÒò×Ó
FasL£ºFas ligand£¬Fas¿¹Ô­ÅäÌå
TRAIL£ºtumor necrosis factor-related apoptosis-inducing ligand£¬Ö×Áö»µËÀÒò×ÓÏà¹ØµòÍöÓÕµ¼ÅäÌå
FADD£ºFas-associated death domain£¬FasÏà¹ØËÀÍö½á¹¹Óò
FasLÊÜÌå±»³ÆÎªFas»òCD95£»TNFÊÜÌåÓÐÁ½ÖÖÑÇÐͼ´TNFR-1ºÍTNFR-2£¬ÆäÖÐTNFR-1ÓÐFADD¶øTNFR-2ûÓУ»DRÓÐÈýÖÖÑÇÐÍ£¬ÆäÖÐDR-3±»³ÆÎªApo-3£¬DR-4¼´TRAILR-1£¬DR-5¼´TRAILR-2¡£
CaspaseÊÇÒ»×é´æÔÚÓÚϸ°ûÖÊÖеĵ°°×ø£¬È«³ÆÎªº¬°ëë×°±ËáµÄÌ춬°±Ëáµ°°×Ë®½âø£¬Äܹ»ÌØÒìÐÔµÄÇиî°Ðµ°°×Ì춬°±Ëá²Ð»ùÉϵÄëļü¡£»î»¯µÄCaspase-8¿É¼¤»îÏÂÓεÄCaspase-3¡¢Caspase-6¡¢Caspase-7£¬¼¤»îϸ°ûµòÍöÏÂÓÎÐźÅͨ·¡£
Caspase-3¡¢Caspase-6¡¢Caspase-7µÄ»îÐÔÊܵ½IAP¼Ò×åµ°°×£¨ÈçXIAP¡¢cIAP1¡¢cIAP2£©µÄÒÖÖÆ£¬¶ø½â³ýIAPµÄÒÖÖÆÒÀÀµÏßÁ£ÌåµÄµòÍöÐźÅSmac/Diablo¡£SmacÄÜÓëIAPµÄBir-½á¹¹Óò½áºÏ£¬½â³ýIAP¶ÔCaspaseµÄÒÖÖÆ×÷Ó㬲¢ÓÕµ¼IAPµÄ½µ½â¡£
IAP£ºinhibitor of apoptosis proteinϸ°ûµòÍöÒÖÖÆµ°°×
SmacÓëIAP½áºÏµÄ¹Ø¼üÊÇN-¶ËµÄ±û°±Ëá¡¢çÓ°±Ëá¡¢¸¬°±Ëá¡¢ÒìÁÁ°±ËáËĸö°±»ùËá²Ð»ù£¬¿ÆÑ§¼ÒÒѾ­ÓÃëÄÄ£Äâ·½·¨£¨peptido-mimetic approach£©¿ª·¢³öС·Ö×Ó»¯ºÏÎ²úÉúÓëSmacÏàËÆµÄ»îÐÔ£¬ÓÕµ¼Ï¸°ûµòÍö¡£
Ñо¿ÈËԱɸѡÁË200,000¸ö»¯ºÏÎѰÕÒÄÜÓëSmacÄ£ÄâÎSmac mimetic, SM£©²úÉúЭͬ×÷ÓõϝºÏÎsynergist£©£¬É¸Ñ¡ÓÃϸ°ûΪT98Gϸ°ûÖ꣨È˽ºÖÊÁöϸ°ûÖ꣩¡£³õɸ·¢ÏÖ2,068»¯ºÏÎï£¬Ëæºó·¢ÏÖ24¸ö»¯ºÏÎïÄÜÔÚ15¦Ì¦¬Å¨¶ÈÏÔÖøÔöÇ¿SMÒÖÖÆÖ×ÁöµÄ»îÐÔ¡£É¾È¥Ï¸°û¶¾ÐÔ´óµÄ£¬Ö»Ê£ÏÂ4¸ö»¯ºÏÎ×ödose-response·ÖÎö£¬×îÖÕɸѡ³ö»¯ºÏÎïA2C2×÷½øÒ»²½Ñо¿¡£
ͼ3. ·¢ÏÖËÀÍöÊÜÌ弤¶¯¼Á

°´ÕÕA2C2µÄ½á¹¹£¬Ñо¿ÈËÔ±ºÏ³ÉÁËÕâÒ»»¯ºÏÎµ«Ææ¹ÖµÄÊǺϳɳöµÄ»¯ºÏÎ¼ÇΪA1£©ÍêȫûÓлîÐÔ£¬Òâζ×ÅA1ÓëA2C2²»ÊÇͬһÖÖÎïÖÊ£¬ÎÊÌâ³öÔÚÄÄÄØ£¿¾­¹ý´óÁ¿NMRºÍLC/MS·ÖÎö£¬È·Ö¤A2C2ʵΪÈýÖÖÖØÅŲúÎA1¡¢C2¡¢A2£©µÄ»ìºÏÎÓлîÐÔµÄÊÇA2+C2¡£ËæºóÊÇһϵÁнṹÐÞÊκϳɣ¬·¢ÏÖ»¯ºÏÎïbioymifiÓкܺõĻîÐÔ£¬ÒÖÖÆÖ×Áöϸ°û²»ÐèÒªSMµÄЭͬ×÷Ó㬲¢ÇÒ¶Ô¶à¸öÖ×Áöϸ°ûÖêÓÐÒÖÖÆ»îÐÔ£¬ÏÂÒ»²½¾ÍÊÇѰÕÒbioymifiµÄ×÷ÓðеãÁË¡£
        ÔÚ¸øÓèbioymifiºÍSMµÄͬʱ£¬¸øÓèpan-caspaseÒÖÖÆ¼ÁZ-VAD£¨Z-VADÄÜÒÖÖÆCaspaseµÄ»îÐÔ£¬×è¶Ïϸ°ûµòÍöÐźÅͨ·£©£¬·¢ÏÖ²»ÄÜÓÐЧÒÖÖÆÖ×Áö£¬Õâ˵Ã÷bioymifi¼¤»îÁËϸ°ûµòÍöÐźÅͨ·¡£ÎªÁ˽øÒ»²½È·¶¨bioymifi×÷ÓÃÓÚÄÄÒ»ÌõÐźÅͨ·£¬Ñо¿ÈËԱʹÓÃsiRNA·Ö±ð³ÁĬT98Gϸ°ûµÄCaspase-8ºÍCaspase-9±àÂëÇø£¬×îÖÕÈ·¶¨bioymifiºÍSMÒÖÖÆµÄÊÇCaspase-8ËùÔÚÐźÅͨ·¼´ÍâÔ´µòÍöÐźÅͨ·¡£
        ÓëCaspase-8ÓйصÄËÀÍöÊÜÌåÓÐFas¡¢TNFR-1¡¢DR3¡¢DR4¡¢DR5µÈÀàÐÍ£¨×¢TNFR-2ÎÞFADD£¬²ÎÓëNF-¦ÊBÓÕµ¼Ï¸°ûµòÍö£¬²»¾­Caspase-8£©£¬bioymifiÓëÄÇÖÖËÀÍöÊÜÌåÓйØÄØ£¿Í¨¹ýRNAiɸѡ£¬³ÁĬDR5»ùÒò£¬Äܹ»Äæ×ªbioymifiÓÕµ¼µÄµòÍö£¬²¢ÇÒbioymifiÏÔʾ³öµÄ½á¹ûÓëTRAIL£¨DR5µÄԭʼÅäÌ壩һÖ¡£
        ËæºóµÄÃâÒß³Áµí£¨immunoprecipitate£©ºÍÃâÒßÓ¡¼£·ÖÎö£¨western blot analysis£©Ö¤Êµ£¬bioymifi»òTRAIL´¦ÀíºóµÄT98Gϸ°ûÖУ¬¾ù¼ì²âµ½FADD¡¢TRADD¡¢RIPK1µÈÓëDISCÏà¹ØµÄµ°°×£¬¶ø¶ÔÕÕϸ°û¼ì²â²»µ½¡£
        ÁíÒ»·½Ã棬¸øÓèTRAILµÄͬʱ¸øÓèTRAIL¿¹Ì壬TRAILʧȥÓÕµ¼Ï¸°ûµòÍöµÄÄÜÁ¦¡£¸øÓèTRAILµÄͬʱ¸øÓèbioymifi£¬ÓÕµ¼Ï¸°ûµòÍöÄÜÁ¦ÎÞÃ÷ÏÔ²îÒì¡£³ÁĬÓÃsiRNA³ÁĬTRAIL»ùÒò£¬²»Ó°ÏìbioymifiÓÕµ¼Ï¸°ûµòÍöµÄÄÜÁ¦¡£
        ΪÁ˽øÒ»²½È·Ö¤bioymifiµÄ×÷Óðе㣬Ñо¿ÈËÔ±½öº¬°ûÍâÇøµÄDR4ÓëDR5£¬·¢ÏÖbioymifiÓëDR5µÄÇ׺ÍÁ¦½ÏºÃ£¬KdÖµÔÚ1.2¦Ì¦¬£¬ÓëDR4ÎÞÇ׺ÍÁ¦¡£DSDµçÓ¾¡¢·Ö×ÓÅÅ×èÉ«Æ×µÈ¼ì²âµ½¸ß·Ö×ÓÁ¿µÄ¾ÛºÏÎ֤Ã÷bioymifiÄÜÓÕµ¼DR5µÄ¾ÛºÏ£¬Ï¸°û³ÉÏñÒ²¹Û²ìµ½ÁËÃ÷ÏÔµÄfoci  ½á¹¹£¬DR4ÎÞÕâЩÏÖÏó¡£
        ×ÛÉÏ£¬·¢ÏÖÁ˵ÚÒ»¸öÑ¡ÔñÐÔС·Ö×ÓDR5¼¤¶¯¼Á¡£
Reference: Small-molecule activation of the TRAIL receptor DR5 in human cancer cells. Nature Chemical Biology. doi:10.1038/nchembio.1153.

ÎÄÏ×ÏÂÔØ£º
»Ø¸´´ËÂ¥

» ±¾Ìû¸½¼þ×ÊÔ´Áбí

  • »¶Ó­¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
    ±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com
  • ¸½¼þ 1 : nchembio.1153.pdf
  • 2013-01-11 20:33:03, 801.94 K

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

·Ö×ÓÉú»¯ÊµÑé¾­Ñé»ýÀÛ Ñо¿Éú×ÊÁÏ ¿¼Ñи´Ï° ѧÊõ±¨¸æ-»¯Ñ§
ÄÉÃ×ÉúÎïÀà Ö×ÁöÑо¿ Óлú useful

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

½ú°ÔÏÉ

гæ (³õÈëÎÄ̳)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ËäÈ»²»ÊÇÏà¹Ø×¨ÒµÁìÓòµÄ¶«Î÷£¬µ«ÊÇÊǺö«Î÷£¬¸ÐлLZ~£¡
´ýÎÒ³¤·¢¼°Ñü£¬Äã¹À¼ÆÒѾ­²»ÐÐÁË~--£¡£¡£¡
3Â¥2013-01-12 16:09:50
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 30 ¸ö»Ø´ð

luck_cc

½ð³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Ñо¿µÄÕâô͸³¹µÄºÃÎÄÕ£¬Ð»Ð»Â¥Ö÷·ÖÏí
ÈÏÕæÄ¿±ê£¬ÓÂÍùֱǰ
5Â¥2013-01-13 10:22:06
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zxh049

гæ (³õÈëÎÄ̳)

лл¥Ö÷£¬ÐÁ¿àÁË

[ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ]
6Â¥2013-01-13 10:48:42
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ΰ×

ľ³æ (ÖøÃûдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
¹ØÒµÏà¹Ø£¬Â¥Ö÷Å£È˰¡£¬Çë¶àÖ¸½Ì¡£

[ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ]
Ììû½µ´óÈÎÓÚÎÒ£¬ÕÕÑù¿àÎÒÐÄÖÇ£¬ÀÍÎÒ½î¹Ç£¬¶öÎÒÌå·ô£¬¿Õ·¦ÎÒÉí£¬Ðи¥ÂÒÎÒËùΪ£¡
7Â¥2013-01-13 11:21:16
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼²©] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.55.1.O.54,¿ÆÄ¿ÆëÈ«,¿ÉÙ¤¼± +3 0XLacIJUOj8D 2026-08-24 3/150 2026-08-25 01:47 by BZKMTicpDhFj
[˶²©¼ÒÔ°] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.551.O.5.4,¿ÆÄ¿È«,¿ÉÙ¤¼± +3 0XLacIJUOj8D 2026-08-24 6/300 2026-08-25 00:11 by BZKMTicpDhFj
[»ù½ðÉêÇë] ûÓÐÈκÎÏûÏ¢-ÊDz»ÊǾÍÁ¹ÁË +7 ͼÀ²Í¼À² 2026-08-24 8/400 2026-08-24 22:00 by maomao_da
[ÂÛÎÄͶ¸å] ÊÛSCI-T0PÎÄÕ£¬ÎÒ:8O.5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 0XLacIJUOj8D 2026-08-24 3/150 2026-08-24 21:59 by BZKMTicpDhFj
[»ù½ðÉêÇë] ÄÜ·ñÍ˳ö²ÎÓëµÄÃæÉÏÏîÄ¿½â³ýÏÞÏî +21 koalala 2026-08-24 24/1200 2026-08-24 19:25 by ¼ÒÓëÔ¶·½
[»ù½ðÉêÇë] ½ñÈÕ²»·Å°ñ£¿Íø´«¹ú×ÔȻԤ¼Æ 8 Ô 27 Èտɲé½á¹û +17 ҽѧÀÏÄк¢ 2026-08-20 21/1050 2026-08-24 14:21 by refreshing11
[»ù½ðÉêÇë] ¹À¼ÆÊÇÖÜËÄ +4 archvillain 2026-08-18 4/200 2026-08-24 13:53 by zzuzxg
[»ù½ðÉêÇë] ·¶½øÖоÙÒ»ÎĵÄÖÐÐÄ˼Ïë +6 Ñ׻ƹóëÐ 2026-08-22 7/350 2026-08-24 11:58 by 6543yes
[»ù½ðÉêÇë] ÅóÓÑȦ¿´µ½µÄ +7 wangzilk 2026-08-18 9/450 2026-08-24 10:50 by cmrandy
[»ù½ðÉêÇë] ÈÃÎÒÖÐÒ»¸öÃæÉϰɣ¡ +13 ´óƼ1987 2026-08-20 16/800 2026-08-24 10:23 by ̫ɵÁË
[»ù½ðÉêÇë] ·Å°ñǰµÄ²»µ­¶¨ 20+4 snowwithsea 2026-08-19 17/850 2026-08-24 10:20 by echo8914667
[»ù½ðÉêÇë] ¿ÆÑй¶ùÌ«ÄÑÁË +18 ÎÒ4´ó°×²Ë 2026-08-20 19/950 2026-08-24 09:47 by ¿­¶÷¹ãÊ¢´ß»¯·ÖÎ
[»ù½ðÉêÇë] ʲôʱºò¿ª½±£¿ +10 CrisMessi 2026-08-18 11/550 2026-08-24 06:50 by ¿ªÐĵÄСʨ×Ó
[»ù½ðÉêÇë] ½ñÌì»ù½ð»á³ö½á¹ûÂð£¿20260819 +16 kkkl_v 2026-08-19 17/850 2026-08-22 16:12 by °¢²¼Abu
[»ù½ðÉêÇë] ʱ¼ä´Á½ñÌ죬20ºÅ±äÁË +5 archvillain 2026-08-20 5/250 2026-08-22 06:12 by hui_daxiao
[»ù½ðÉêÇë] ¿´À´½ñÌì²»»á·Å°ñÁË£¿ +8 chengyan1220 2026-08-21 11/550 2026-08-21 17:52 by dcqxinyang
[»ù½ðÉêÇë] »ù½ð°¡»ù½ð +4 longfie172 2026-08-20 4/200 2026-08-21 08:58 by mark mao
[»ù½ðÉêÇë] ÖØÒªÏûÏ¢£¬ÖÐÎçϵͳÔÚά»¤ +11 yuleib84 2026-08-18 12/600 2026-08-20 11:09 by xskun
[»ù½ðÉêÇë] Ã÷Ìì·Å°ñ£¿ +5 Shxjjxjkx 2026-08-18 5/250 2026-08-18 18:14 by -´ó´ó´ó´ó´ó-
[»ù½ðÉêÇë] ½ñÌìά»¤ÏµÍ³Î¬»¤ ×£ËùÓÐÈË ¸ßÖÐ +8 gjjjzhong 2026-08-18 9/450 2026-08-18 13:01 by ¼ÒÓëÔ¶·½
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û